繁荣中国
发表于 2025-3-30 08:35:29
make progress with the support of basic and clinical research. This work is a collection of material that deals with the management of critically ill patients, published on the occasion of the 13th APICE congress in November 1998, which celebrated 40 years of Critical Care Medicine.978-88-470-0051-3978-88-470-2145-7
发酵
发表于 2025-3-30 13:25:01
A Life in Critical Care monitoring the internal functions of an incapacitated patient during the critical time of his or her acute disease. Hence, its field has a broader scope than resuscitation, the goal of which is to bring life back to an apparently dead person. As early as 1954, at the Claude Bernard Hospital in Pari
发炎
发表于 2025-3-30 17:43:48
http://reply.papertrans.cn/16/1558/155755/155755_53.png
猛击
发表于 2025-3-31 00:29:28
http://reply.papertrans.cn/16/1558/155755/155755_54.png
Mortar
发表于 2025-3-31 01:33:10
Early Goal-Directed Invasive and Noninvasive Monitoring of High Risk Postoperative and Septic Surgice observer-dependant. By contrast, shock is easy to recognize in the late stages when therapy may be ineffective. If shock could be recognized earlier and treated more vigorously to physiologic endpoints, improved outcome might be anticipated. A major problem is that shock is routinely recognized by
迅速飞过
发表于 2025-3-31 06:55:28
Postresuscitation Myocardial Dysfunctionto long-term and functional survival. Yet of the approximately 39% of victims who are initially resuscitated successfully, as few as 3% represent hospital survivors [., .]. This large fall off in survival reflects what we now recognize as two discrete stages of cardiac resuscitation. The first stage
moratorium
发表于 2025-3-31 11:22:47
http://reply.papertrans.cn/16/1558/155755/155755_57.png
规范就好
发表于 2025-3-31 13:31:29
http://reply.papertrans.cn/16/1558/155755/155755_58.png
中世纪
发表于 2025-3-31 18:02:11
Is Mortality the Only Outcome Measure in ICU Patients? The choice of the outcome measure employed will vary according to the agent/technique being assessed but in intensive care medicine, the majority of clinical trials currently focus on the 28 day all-cause mortality rate. This measure may, however, not necessarily be the most appropriate, and we wil